www.fdanews.com/articles/85584-afferenz-enters-2006-with-vision-for-the-future-of-clinical-trials
AFFERENZ ENTERS 2006 WITH VISION FOR THE FUTURE OF CLINICAL TRIALS
March 27, 2006
Afferenz, a leading eClinical software
and services company that addresses the information technology needs within the
clinical trials environment, continues to change the way organizations execute
their clinical development initiatives. Following a strong year of global growth,
and experience in running ASP trials that dates back to 1999, 2006 marks Afferenz's
transition from a hidden industry gem to one with a substantial market position.
With a vision for end-to-end solutions for clinical development for today and
beyond, Afferenz is determined to create the new standard for clinical data and
trial management, and efficiencies in drug, biotechnology, and medical device
development.
Business
Wire